Alveron Pharma is developing a unique coagulation

platform technology with the world's first

cyclodextrin-based anticoagulant reversal drug 

Alveron Pharma's proprietary cyclodextrin-based compounds accelerate, but not initiate, coagulation via a unique mechanism. These compounds can therefore be used as systemic anti-bleeding agents, and our lead program is focused on developing a truly universal anticoagulant reversal agent.

Learn more
Contact us

Alveron Pharma

NovioTech Campus

Transistorweg 5

6534 AT Nijmegen

The Netherlands


Postal address:

Pivot Park 

Henry Chesbrough building

Kloosterstraat 9 

5349 AB Oss

The Netherlands

© 2019 Alveron Pharma, all rights reserved.  Design by Brightlands Maastricht Health Campus